Additional file 13: Figure S11. Correlation of the risk signature with clinicopathologic factors in GSE30219 datasets. The signature was positively correlated with T stage and N stage in GSE30219 datasets (Pâ<â0.05). But there was no correlation of the signature and recurrence
Additional file 2: Table S2. The coefficient value of 30 immune related risk genes
Abstract Background Lung cancer has become the most common cancer type and caused the most cancer de...
Additional file 1: Table S1. Validating the prediction power of the gene signature for OS in the com...
Additional file 14: Figure S12. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 15: Figure S13. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 11: Figure S9. The KaplanâMeier survival analysis of the signature for LUAD subgro...
Additional file 10: Figure S8. The KaplanâMeier survival analysis of the signature for LUAD subgro...
Additional file 12: Figure S10. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 9: Figure S7. The KaplanâMeier survival analysis of the signature for LUAD subgrou...
Additional file 4: Figure S2. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 7: Figure S5. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 5: Figure S3. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 6: Figure S4. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 3: Figure S1. The Kaplan–Meier survival analysis for the 30 immune related genes in ...
Additional file 8: Figure S6. The Kaplan–Meier survival analysis of the signature for LUAD subgroup ...
Additional file 2: Table S2. The coefficient value of 30 immune related risk genes
Abstract Background Lung cancer has become the most common cancer type and caused the most cancer de...
Additional file 1: Table S1. Validating the prediction power of the gene signature for OS in the com...
Additional file 14: Figure S12. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 15: Figure S13. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 11: Figure S9. The KaplanâMeier survival analysis of the signature for LUAD subgro...
Additional file 10: Figure S8. The KaplanâMeier survival analysis of the signature for LUAD subgro...
Additional file 12: Figure S10. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 9: Figure S7. The KaplanâMeier survival analysis of the signature for LUAD subgrou...
Additional file 4: Figure S2. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 7: Figure S5. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 5: Figure S3. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 6: Figure S4. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 3: Figure S1. The Kaplan–Meier survival analysis for the 30 immune related genes in ...
Additional file 8: Figure S6. The Kaplan–Meier survival analysis of the signature for LUAD subgroup ...
Additional file 2: Table S2. The coefficient value of 30 immune related risk genes
Abstract Background Lung cancer has become the most common cancer type and caused the most cancer de...
Additional file 1: Table S1. Validating the prediction power of the gene signature for OS in the com...